Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

Archives of General Psychiatry
S S O'MalleyB Rounsaville

Abstract

The goal of this study was to examine the persistence of naltrexone's effects on drinking outcomes among alcoholics following discontinuation of treatment and to determine whether coping skills therapy improves long-term outcomes compared with supportive therapy. Eighty of 97 alcohol-dependent subjects randomized to receive naltrexone or placebo and either coping skills therapy or supportive therapy for 12 weeks were assessed at a 6-month off-treatment follow-up. Subjects who received naltrexone were less likely to drink heavily or to meet criteria for alcohol abuse or dependence than subjects who received placebo. The effect of naltrexone therapy on abstinence rates persisted only through the first month of follow-up. Coping skills therapy was associated with decreased levels of drinking among subjects who received placebo. Psychotherapy condition, however, did not predict alcohol diagnosis at follow-up. Some but not all of the benefits resulting from short-term naltrexone treatment persist after discontinuation of treatment. The findings suggest that continued treatment with naltrexone may be beneficial for some patients.

Citations

Apr 1, 2003·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·David H EpsteinKenzie L Preston
Apr 2, 2008·Journal of Consulting and Clinical Psychology·Nancy M PetryBenjamin Morasco
Aug 16, 2008·The New England Journal of Medicine·Raymond F Anton
Dec 19, 2008·Behavior Modification·Richard A BrownAlan A Gordon
Jan 1, 2007·Indian Journal of Psychiatry·Sandeep GroverGaurav Bhateja
Nov 26, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Barbara J Mason
Oct 12, 2005·Current Psychiatry Reports·Kathleen M Carroll
Nov 15, 2001·Current Psychiatry Reports·G O'LearyR D Weiss
Dec 24, 2002·Journal of Substance Abuse Treatment·Gabriel RubioTomás Palomo
Jan 5, 2001·European Child & Adolescent Psychiatry·N ChabaneM C Mouren-Simeoni
Oct 9, 2002·Addictive Behaviors·G Alan Marlatt, Katie Witkiewitz
May 4, 2005·Biological Psychiatry·Ismene L PetrakisUNKNOWN VA New England VISN I MIRECC Study Group
Nov 9, 2000·British Journal of Clinical Pharmacology·S J PorterJ M White
Feb 15, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael SoykaUNKNOWN WFSBP Task Force on Treatment Guidelines for Substance Use Disorders
Jun 29, 2010·Pharmacology, Biochemistry, and Behavior·Susana Peciña, Kyle S Smith
Jul 8, 2008·Progress in Neurobiology·Ilana Roth-DeriGal Yadid
Feb 20, 2004·The American Journal on Addictions·Mary E McCaul, Nancy M Petry
Apr 2, 2004·Journal of Neurochemistry·Michael S CowenAndrew J Lawrence
Jan 28, 2009·Alcoholism, Clinical and Experimental Research·Karl MannUNKNOWN PREDICT Study Research Team
Jun 11, 2008·Alcoholism, Clinical and Experimental Research·David W OslinCharles P O'Brien
Jan 25, 2008·Alcoholism, Clinical and Experimental Research·Robert MirandaJohn McGeary
May 15, 2013·Addiction·Meenakshi Sabina SubbaramanJennifer Ahern
Apr 13, 2012·The American Journal on Addictions·Edward J Khantzian
Dec 3, 2009·Alcoholism, Clinical and Experimental Research·Katherine G HillStephen W Kiefer
Dec 22, 2004·Journal of Substance Abuse Treatment·Thamizan TuckerHenry Jackson
Sep 4, 2004·Addictive Behaviors·David J KavanaghJon May
May 26, 2004·Physiology & Behavior·L M Oswald, G S Wand
Jul 28, 2004·Drug and Alcohol Dependence·Kathleen M CarrollBruce J Rounsaville
Dec 20, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Hendrik G RoozenAd J F M Kerkhof
Nov 4, 2005·European Journal of Pharmacology·Falk Kiefer, Karl Mann
Jul 1, 1999·The Psychiatric Clinics of North America·H R KranzlerC Oncken
Apr 18, 2000·Emergency Medicine Clinics of North America·R Olmedo, R S Hoffman
Nov 20, 2004·The Psychiatric Clinics of North America·Mehmet Sofuoglu, Thomas R Kosten
Jan 9, 2004·The Psychiatric Clinics of North America·Mark P McGovern, Kathleen M Carroll
Mar 21, 2000·The American Journal of Medicine·D A FiellinP G O'Connor
Jan 13, 2015·Alcoholism, Clinical and Experimental Research·Henry R KranzlerJonathan Covault
Jun 1, 2013·The American Journal of Drug and Alcohol Abuse·Joanna JaroszGünther Krumpl
May 2, 2014·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Susan E CollinsRichard K Ries

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.